KALV: KalVista Pharmaceuticals Inc

14.05 USD 0.23 (1.66%)

Sektor: Gesundheitswesen Basis: US Dollar Gewinnwährung: US Dollar

Der Wechselkurs von KALV hat sich für heute um 1.66% verändert. Im Laufe des Tages wurde das Instrument von einem Tief von 13.68 bis zu einem Hoch von 14.34 gehandelt.

Verfolgen Sie die KalVista Pharmaceuticals Inc-Dynamik. Mit Echtzeit-Kursen können Sie schnell auf Marktveränderungen reagieren. Indem Sie zwischen verschiedenen Zeitrahmen wechseln, können Sie Kurstrends und -dynamik nach Minuten, Stunden, Tagen, Wochen und Monaten verfolgen. Nutzen Sie diese Informationen, um Marktveränderungen vorherzusagen und fundierte Handelsentscheidungen zu treffen.

Vollbild-Chart

KALV News

Seeking Alpha 09:02 KalVista's EKTERLY Faces Shrinking Market, Oral Competitor Threat (Downgrade) (KALV)
Investing 12:32 European regulator recommends approval of first oral HAE treatment
Investing 08:59 Kalvista Pharmaceuticals stock maintains Market Outperform rating at JMP
Investing 09:05 JMP reiterates Market Outperform rating on Kalvista stock after UK approval
Investing 20:12 UK approves first oral treatment for hereditary angioedema attacks
Seeking Alpha 19:24 Astria: Betting On Navenibart In The Crowded HAE Arena
Benzinga 12:14 Ultragenyx Pharmaceutical, Apple And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Apple (NASDAQ:AAPL), Above Food Ingredients (NASDAQ:ABVE)
Investing 11:25 Kalvista stock maintains Buy rating at H.C. Wainwright on favorable Ekterly label
Investing 01:01 Kalvista Pharma CEO Palleiko sells $517k in shares
Investing 00:52 Kalvista Pharma chief development officer sells $474k in shares
Investing 15:15 Leerink Partners reiterates Outperform rating on Kalvista stock as Ekterly launch begins
Seeking Alpha 19:52 KalVista: FDA Approval Of EKTERLY As Oral On-Demand HAE Drug Is Just Beginning (KALV)
Benzinga 14:03 Meta Platforms To Rally Around 9%? Here Are 10 Top Analyst Forecasts For Tuesday - Abbott Laboratories (NYSE:ABT), Danaher (NYSE:DHR)
Investing 08:53 Kalvista stock price target raised to $27 from $19 at JMP on Ekterly pricing
Investing 19:27 Kalvista stock rises as Leerink raises price target on FDA approval
Investing 18:01 Tesla, Circle Internet Surge Among Monday’s Market Cap Stock Movers
Investing 17:11 KalVista stock price target raised to $37 from $22 at BofA on Ekterly approval
Investing 14:36 Kalvista stock jumps as Stifel reiterates Buy rating on Ekterly approval
Investing 14:31 Tesla, Oracle among Monday’s market cap stock movers
Benzinga 14:05 KalVista Pharmaceuticals, Cogent Biosciences, WNS And Other Big Stocks Moving Higher On Monday - Amber International (NASDAQ:AMBR), Baidu (NASDAQ:BIDU)
Investor's Business Daily 13:12 KalVista Ends Its Unexpectedly Messy Path To Approval In HAE Treatment
Investing 12:22 US FDA approves KalVista Pharma’s swelling disorder drug, shares rise
Benzinga 11:47 Why Is KalVista Pharmaceuticals Stock Soaring On Monday? - KalVista Pharma (NASDAQ:KALV)
Investing 11:26 KalVista stock soars after FDA approves first oral HAE treatment

Tagesspanne

13.68 14.34

Jahresspanne

7.31 16.32

Vorheriger Schlusskurs: 13.75
Eröffnung: 13.82

Bid: 14.05
Ask: 14.35

Tief: 13.68
Hoch: 14.34

Volumen: 1.843 K

Tagesänderung: 1.66%
Monatsänderung: 24.89%

6-Monatsänderung: 60.39%
Jahresänderung: -5.32%

30 Juli, Mittwoch